Skip to main content

ADVERTISEMENT

Erdal Cavusoglu, MD

Original Contribution
09/15/2008
ABSTRACT: Background. We designed a study to compare the novel point-of-care assay Hemonox clotting time (Hemonox-CT) with the activated clotting time (ACT) and anti-Xa activity to monitor the anticoagulation effects of enoxaparin and...
ABSTRACT: Background. We designed a study to compare the novel point-of-care assay Hemonox clotting time (Hemonox-CT) with the activated clotting time (ACT) and anti-Xa activity to monitor the anticoagulation effects of enoxaparin and...
ABSTRACT: Background. We...
09/15/2008
Journal of Invasive Cardiology